Skip to main content
Equibles

Squarepoint Ops LLC

Position in ABBV — AbbVie Inc.

CIK 1642575 NEW YORK, NY
Back to ABBV Full portfolio

Position in ABBV

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$23,138,298
-$19,026,705 QoQ
Shares Held
91,950
-52.6% QoQ
Ownership
0.005%
of shares outstanding
% of Portfolio
0.05%
of 13F equity value
Holder Rank
#564
of 4,150 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority Sole 0% Shared 100% None 0%

Common Shares in ABBV Over Time

Shares Held

Position Value (USD)

Derivatives in ABBV

reported options exposure · as of Jun 30, 2026
CallValue
$16,432,092
CallShares
65,300
PutValue
$15,903,648
PutShares
63,200

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Drug Manufacturers - General

Healthcare · as of Jun 30, 2026

Squarepoint Ops LLC holds $1,171,914,058 across 14 Drug Manufacturers - General names. ABBV ranks #7 (2.0% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 JNJ
Johnson & Johnson
 1,247,079 $316,720,653
2 LLY
ELI LILLY & Co
 245,569 $294,542,850
3 GILD
Gilead Sciences, Inc.
 1,823,224 $230,346,120
4 MRK
Merck & Co., Inc.
 909,676 $116,893,366
5 PFE
Pfizer Inc
 3,310,002 $79,704,848
6 AMGN
Amgen Inc
 208,010 $75,324,581
7 ABBV
AbbVie Inc.
This page 		91,950 $23,138,298
8 BMY
Bristol Myers Squibb Co
 324,626 $18,704,950

All Filings in ABBV

Export CSV
50 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $15,903,648 63,200
2026-06-30 $16,432,092 65,300
2026-06-30 $23,138,298 91,950
2026-03-31 $9,939,293 45,700
2026-03-31 $12,092,444 55,600
2026-03-31 $42,165,003 193,871
2025-12-31 $18,621,935 81,500
2025-12-31 $33,976,463 148,700
2025-12-31 $17,039,413 74,574
2025-09-30 $19,935,594 86,100
2025-09-30 $20,537,598 88,700
2025-09-30 $30,886,972 133,398
2025-06-30 $92,106,314 496,209
2025-06-30 $37,792,232 203,600
2025-06-30 $39,889,738 214,900
2025-03-31 $54,035,208 257,900
2025-03-31 $11,767,690 56,165
2025-03-31 $47,665,800 227,500
2024-12-31 $38,631,980 217,400
2024-12-31 $13,020,079 73,270
2024-12-31 $26,992,630 151,900
2024-09-30 $23,026,168 116,600
2024-09-30 $23,697,600 120,000
2024-09-30 $18,824,188 95,322
2024-06-30 $16,397,312 95,600
2024-06-30 $20,029,934 116,779
2024-06-30 $20,668,160 120,500
2024-03-31 $8,719,130 47,881
2024-03-31 $49,713,300 273,000
2024-03-31 $69,981,030 384,300
2023-12-31 $17,992,017 116,100
2023-12-31 $36,638,782 236,425
2023-12-31 $1,456,718 9,400
2023-09-30 $37,052,887 248,577
2023-09-30 $2,206,088 14,800
2023-09-30 $3,696,688 24,800
2023-06-30 $4,082,319 30,300
2023-06-30 $62,649,450 465,000
2023-06-30 $3,341,304 24,800
2023-03-31 $223,118 1,400
2023-03-31 $1,992,125 12,500
2022-12-31 $6,577,527 40,700
2022-12-31 $10,426,269 64,515
2022-12-31 $6,868,425 42,500
2022-09-30 $1,140,785 8,500
2022-09-30 $1,328,679 9,900
2022-06-30 $2,664,984 17,400
2022-06-30 $2,649,668 17,300
2022-03-31 $826,761 5,100
2022-03-31 $11,785,397 72,700

Report a Problem

Category
Description
Email (optional, for follow-up)